Integral Health Asset Management LLC acquired a new position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 100,000 shares of the company’s stock, valued at approximately $4,523,000. Integral Health Asset Management LLC owned 0.13% of […]